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A Ab bs st tr ra ac ct t
B Ba ac ck kg gr ro ou un nd d: :   This study examined: (1) levels of cancer-specific distress more than one year after genetic
counselling for hereditary nonpolyposis colorectal cancer (HNPCC); (2) associations between sociodemographic,
clinical and psychosocial factors and levels of distress; (3) the impact of genetic counselling on family relationships,
and (4) social consequences of genetic counselling.
M Me et th ho od ds s: :   In this cross-sectional study, individuals who had received genetic counselling for HNPCC during
1986-1998 completed a self-report questionnaire by mail.
R Re es su ul lt ts s: :   116 individuals (81% response rate) completed the questionnaire, on average 4 years after the last
counselling session. Of all respondents, 6% had clinically significant levels of cancer-specific distress (Impact
of Event Scale, IES). Having had contact with a professional psychosocial worker for cancer risk in the past 
10 years was significantly associated with higher levels of current cancer specific distress. Only a minority of
the counselees reported any adverse effects of genetic counselling on: communication about genetic counselling
with their children (9%), family relationships (5%), obtaining life insurance (8%), choice or change of jobs (2%),
and obtaining a mortgage (2%).
C Co on nc cl lu us si io on n: : On average, four years after genetic counselling for HNPCC, only a small minority of counselled
individuals reports clinically significant levels of distress, or significant family or social problems.
I In nt tr ro od du uc ct ti io on n
Between 1 and 6% of all colorectal cancers represent
a well-delineated genetic syndrome, hereditary
nonpolyposis colorectal cancer (HNPCC or Lynch
syndrome) [1, 2]. Before 1993, cancer risk estimates
and colon screening recommendations were based on
family history only [3]. Since 1993, genetic testing for
HNPCC has been possible for at-risk families [4-7].
Carriers of HNPCC-related mutations have a lifetime
risk of up to 80% of developing colorectal cancer [8].
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the proven carriers of HNPCC-related mismatch repair
(MMR) genes are advised to undergo a colonoscopy
every 1-2 years [10]. In a recent paper, we reported on
compliance with recommended colon-screening advice
[11]. The focus of the current paper is on the long-term
psychosocial impact of genetic counselling for hereditary
nonpolyposis colorectal cancer.
Most studies on the psychosocial consequences of
genetic counselling and testing for breast or colorectal
cancer have not shown significantly increased mean
levels of psychological distress during the 12 months
immediately following testing [12-22]. However, despite
the fact that mean levels of distress are not increased, it
has been reported that 3% to 24% of individuals
experience heightened levels of distress after genetic
counselling and/or testing for colorectal cancer [16-18].
Factors that are reported to be associated with
heightened levels of distress during or after counselling
or testing include: high perceived cancer risk [23],
younger age [23], education level [18, 23] (with
conflicting findings with regard to the direction of the
association), female gender [18], baseline mood
disturbance [19], genetic test result (carriers and those
awaiting test results) [16], fewer sources of social contacts
[18, 19], and less satisfaction with those contacts [18].
Most studies on genetic counselling for cancer have
generally focused on the first 12 months after counselling
[12, 13]. However, in order to better counsel high-risk
families, we need to understand the long-term impact of
undergoing genetic counselling and mutation testing [24].
Genetic counselling may not only affect the individual
being counselled, but also family relationships [25].
Although most individuals from HNPCC families have
been found to be willing to share information about
HNPCC with family members [26], the initial clinic
attendee may find it particularly difficult to inform
relatives, especially distant relatives [27, 28] or in
emotionally distant relationships [29], since the
information may have a disturbing impact on family
relationships [30]. However, no information is currently
available on the extent to which genetic counselling
affects family relationships in the years following genetic
counselling and testing for HNPCC [31].
Information provided during genetic counselling/
testing may also have significant consequences in the
areas of insurance, employment and family planning
[32]. A common concern is that personal information
about the results of genetic counselling may be
required by insurance companies, and that this may
result in limited coverage, increased costs, or outright
denial of insurance [33]. This fear of insurance
discrimination has been reported to be associated with
the decision not to undergo genetic testing for breast
cancer; however, no evidence of actual insurance
discrimination from BRCA1/2 testing has been
observed [34].
Discriminatory practices related to employment, 
life-insurance or obtaining a mortgage have not yet
been documented in the Netherlands and, to our
knowledge, no systematic study of this issue has been
carried out in this area of cancer genetics. Only one
Finnish study reported on individuals tested for HNPCC:
no differences were found between carriers and non-
carriers in life or health insurance coverage within 
12 months after genetic counselling and testing [35].
Finally, with regard to family planning, it has been
reported that individuals who tested positive for a BRCA1
gene mutation had more negative attitudes towards
reproductive intentions than non-carriers [36]. To our
knowledge, no studies have investigated this issue in
HNPCC.
The present study was carried out to investigate: (1)
levels of cancer-specific distress more than one year
after genetic counselling for HNPCC; (2) the
association between sociodemographic, clinical and
psychosocial factors and levels of distress; (3) the
impact of genetic counselling on family relationships;
and (4) social consequences of genetic counselling.
M Me et th ho od ds s
P Pa ar rt ti ic ci ip pa an nt ts s
This cross-sectional study recruited all individuals
who were counselled between 1986 and 1998 at one
of three family cancer clinics in Amsterdam for HNPCC.
These individuals represent a clinical case series. The
participating hospitals were the VU University Medical
Center (VUMC), the Netherlands Cancer Institute –
Antoni van Leeuwenhoek Hospital (NKI-AVL), and the
Academic Medical Center (AMC). Included were all
individuals who met the Amsterdam-I criteria, [9] and
had completed genetic counselling for HNPCC.
Additional inclusion criteria were basic fluency in Dutch,
having had at least one face-to-face counselling session
with a clinical geneticist (physician), having been
informed about the risk of developing colorectal cancer
(again), and not being in a terminal stage of illness.
G Ge en ne et ti ic c  c co ou un ns se el ll li in ng g
In this paper we use the term “genetic counselling”
to refer to the entire counselling process. This includes
an intake session during which a pedigree is obtained,
and one or more counselling sessions with a genetic
counsellor or clinical geneticist during which H He er re ed diit ta ar ry y  C Ca an nc ce er r  iin n  C Clliin niic ca all  P Pr ra ac ct tiic ce e 2007; 5(2) 61
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a diagnosis is made, risk counselling is provided, and
preventive health recommendations are discussed. The
risk estimation can be based on the family history only,
or also on the results of a DNA test. If a family meets
the clinical criteria for HNPCC [9] DNA testing (testing
for MMR genes) is usually offered.
P Pr ro oc ce ed du ur re es s
All eligible individuals received a letter from their
clinical geneticist explaining the aim of the study, and 
a self-report questionnaire. The completed questionnaire
could be returned in a postage-free envelope. If the
questionnaire was not returned within three weeks, 
a reminder and a copy of the questionnaire were sent.
The study was approved by the institutional review boards
of the three participating hospitals.
M Me ea as su ur re es s
S So oc ci io od de em mo og gr ra ap ph hi ic c   a an nd d   c cl li in ni ic ca al l   d da at ta a: : The following
data were obtained from the medical records and/or
the questionnaire: age, gender, marital status, level of
education, number and age of children, personal
history of cancer (i.e. treated for cancer, treated for
benign polyps, not treated for cancer); actual cancer
risk (1. proven carrier of HNPCC mutation, 2. clinical
diagnosis of HNPCC, i.e. meeting the Amsterdam-I
criteria, and 3. non-carrier, i.e. mutation-negative in
a family with a proven pathogenic mutation); and dates
and number of counselling sessions.
P Pe er rc ce ei iv ve ed d   r ri is sk k: : Respondents were asked to report their
perceived risk of developing cancer (again) relative to
that of the “average person in the Dutch population” (item
adapted from Lerman, Seay, et al. [37]). The response
categories were: “much higher”, “somewhat higher”,
“the same”, and “lower”.
I In nv vo ol lv ve em me en nt t   i in n   t th he e   d di is se ea as se e   p pr ro oc ce es ss s   o of f   a a   r re el la at ti iv ve e: :
Since personal involvement in the illness experience of
a relative is hypothesized to be related to the level of
cancer-related distress [38], respondents were first
asked to report the number of first and second degree
relatives with colorectal cancer, and then the extent to
which they were involved in the disease process of one
or more of those relatives (response categories: “very
much”, “quite a bit”, “a little”, “not at all”).
P Pr ro of fe es ss si io on na al l    s su up pp po or rt t: : To investigate whether
professional psychological counselling for cancer
worries during the past 10 years (with a psychologist,
psychiatrist, social worker or general practitioner) was
associated with present levels of distress, a comparison
was made between those who had ever had such
contact during the past 10 years and those who had
never had such contact in that period.
C Ca an nc ce er r- -s sp pe ec ci if fi ic c   d di is st tr re es ss s: :   The Intrusion subscale of
the Impact of Event Scale (IES) [39] was used to assess
the frequency and severity of intrusive thoughts about
the familial occurrence of colorectal cancer. The
Intrusion scale consists of seven Likert-type items
(response categories: “not at all” to “often”). The Dutch
translation of the IES [40] has proven to be a valid and
reliable instrument for assessing event-specific
psychological distress (Cronbach’s alpha of the
Intrusion subscale in the present study = 0.89). The
Intrusion subscale has also proven to be a valid and
reliable instrument in populations at increased risk of
developing hereditary breast cancer [41, 42]. In the
present study “the event” was defined as “cancer in the
family”. The items were related to this situation. The
cut-off score of 20 on the IES subscale was used to
indicate a “clinically important reaction” [43, 44].
C Co on ns se eq qu ue en nc ce es s   f fo or r   f fa am mi il ly y   r re el la at ti io on ns sh hi ip ps s: :   Respondents
were first asked whether their relationship with family
members had changed due to the genetic counselling
process (response categories: “improved”, “deteriorated”,
“changed but not for the better or worse”, “no change”).
Three additional questions were posed regarding
communication with relatives about the genetic
counselling process, i.e. did the respondent experience
problems: with (1) first-degree relatives (siblings, parents),
(2) their children, or (3) second-degree relatives (response
categories: yes, no, not applicable).
C Co on ns se eq qu ue en nc ce es s   f fo or r   f fu ut tu ur re e   p pl la an nn ni in ng g   a an nd d   s so oc ci ia al l   i is ss su ue es s: :
Respondents were asked a single question about
whether the genetic counselling had had an impact
on their plans for having children. Additionally, a series 
of questions was posed as to whether, due to the
genetic counselling, problems had been experienced
with intimate relationships, choice or change in
employment, obtaining a mortgage, or obtaining life
insurance (response categories for each topic: yes,
no, not applicable). These questions were based on
a questionnaire used previously in a study of long-term
survivors of Hodgkin’s lymphoma [45].
S St ta at ti is st ti ic ca al l  a an na al ly ys se es s
Descriptive statistics were generated to characterize
the study sample in terms of demographics and clinical
background, and to describe the experienced
consequences of genetic counselling. Levels of cancer-
specific distress were examined as a function of
sociodemographic, clinical and psychosocial variables.
Depending on the level of measurement and
number of categories, Student’s t-test, chi-square
statistic or analyses of variance were used. In the case
of multiple comparisons, the post-hoc Scheffe test wasH He er re ed diit ta ar ry y  C Ca an nc ce er r  iin n  C Clliin niic ca all  P Pr ra ac ct tiic ce e 2007; 5(2) 62
used to investigate subgroup differences. A regression
analysis was carried out to determine which variables
were significantly (i.e. p<0.05) associated with
psychological distress following the genetic counselling.
In this analysis, sociodemographic variables (age,
gender, level of education), clinical variables (personal
history of cancer, actual risk, time since last counselling,
number of face-to-face counselling sessions with
clinical geneticist) and psychosocial variables
(perceived risk, professional support in the past,
involvement in disease process of relative) were entered
in the model. To control for potential clustering effects
caused by the fact that some participants were
members of the same family, a general linear model
for regression analyses was used, inputting family
membership as a random factor in the model.
R Re es su ul lt ts s
R Re es sp po on ns se e
In total, 143 individuals who were counselled for
HNPCC in the period 1986 to 1998 were invited to
participate in the study. Of these, 116 (81%) completed
the questionnaire. The respondents were, on average,
older than the non-respondents (mean age = 43.4 years
(sd=11.2) versus 37.9 years (sd=13.0); p=0.05). No
statistically significant differences were found between
the respondents and the non-respondents for gender,
personal history of cancer, risk of developing cancer,
hospital, or number of affected first-degree relatives. 
The 116 respondents stemmed from 29 families.
S So oc ci io od de em mo og gr ra ap ph hi ic c  a an nd d  c cl li in ni ic ca al l  c ch ha ar ra ac ct te er ri is st ti ic cs s
Table 1 shows that, in the responding group, men
and women were equally represented, and 60% had
never had any signs (precursors) of colorectal cancer. In
total, 31 individuals were found to be a carrier of an
HNPCC mutation (20 hMLH1, 11 hMSH2). Twenty-five
individuals were found not to be a carrier of a known
mutation in their family (non-carriers). In addition, the
mutation status of 60 individuals was unknown; however,
their family history was consistent with HNPCC. Of this
group, 12 had themselves undergone genetic testing for
MMR mutations, resulting in an inconclusive test result.
Others had not undergone testing themselves. No
statistically significant differences in distress levels were
found between those individuals classified as “clinical
HNPCC” who had and who had not undergone genetic
testing. For this reason, and because of their comparable
risk estimation and screening advice, these counselees
were taken together as one group.
The mean time elapsed between the final counselling
session and the completion of the questionnaire was 
3.8 years (sd=2.3). Prior to the contacts with the clinical
geneticist most individuals had had a standard intake
session with a genetic nurse. In addition, 29% of the
respondents had a single face-to-face counselling
session with the clinical geneticist (physician); the
remaining 71% had two or more such sessions.
D Di is st tr re es ss s
The mean score on the IES-Intrusion subscale was
5.3 (sd=6.9; n=108). Six percent (n=6) scored above
the cut-off score of 20, indicating a clinically significant
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T Ta ab bl le e   1 1. .   Sociodemographic and clinical characteristics of respondents
(N=116)
C Ch ha ar ra ac ct te er ri is st ti ic cs s N N % %
g ge en nd de er r
male 60 52
female 56 48





t tr re ea at te ed d   f fo or r   c ca an nc ce er r
yes 21 18
benign polyp 25 22
no 70 60
a ac ct tu ua al l   r ri is sk k
mutation carriers 31 27
clinical diagnosis of HNPCC 60 52
non-carrier 25 22
t ti im me e   s si in nc ce e   l la as st t   c co ou un ns se el ll li in ng g   ( (y ye ea ar rs s) )
mean (SD) 3.8 (2.3)
median (range) 3 (1-11)
n nu um mb be er r   o of f   c co ou un ns se el ll li in ng g   s se es ss si io on ns s
mean (SD) 2.4 (2.0)
13 2 2 9
2 or more 84 71H He er re ed diit ta ar ry y  C Ca an nc ce er r  iin n  C Clliin niic ca all  P Pr ra ac ct tiic ce e 2007; 5(2) 63
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level of cancer-specific distress (1 carrier, 
4 clinical HNPCC, 1 non-carrier). Table 2 displays the
mean scores and standard deviations on the distress
scale as a function of various sociodemographic and
clinical characteristics. Those who had received
professional psychosocial support in the past reported
significantly higher levels of current cancer-specific distress
(p=0.002) than those who did not receive such support.
In addition, those who had been treated for cancer or 
a benign polyp tended to report more cancer-specific
distress than healthy individuals (p=0.06). No statistically
significant differences were found in levels of cancer-
specific distress as a function of age, gender, level of
education, actual or perceived cancer risk, close
involvement in the disease process of one or more
relatives, or time since last counselling.
In the regression analysis, only one variable was
found to be significantly associated with cancer-specific
distress at the multivariate level: “having had contact
with a professional psychosocial worker in the past 
10 years for cancer risk” (p=0.05). Gender was not
significantly associated with cancer-specific distress,
but women tended to report more distress then men
(p=0.06).
C Co on ns se eq qu ue en nc ce es s  o of f  c co ou un ns se el ll li in ng g  f fo or r  f fa am mi il ly y  r re el la at ti io on ns sh hi ip ps s
Table 3 shows that 7 (9%) of the 79 individuals with
children experienced problems in communication about
genetic counselling with their children. Additionally, 
7 respondents (7%) reported experiencing problems in
discussing this issue with their first-degree relatives, and
another 7 (8%) with their second-degree relatives.
Of the 109 counselees who answered the questions
on family relationships, five (5%) reported that family
relationships had worsened as a result of genetic
counselling. In 12 cases (11%) relationships had
improved, and in another 14 (13%) relationships had
changed, but not for the better or the worse. For the
majority of the respondents genetic counselling had
had no significant impact on family relationships.
C Co on ns se eq qu ue en nc ce es s  o of f  g ge en ne et ti ic c  c co ou un ns se el ll li in ng g  f fo or r  s so oc ci ia al l  i is ss su ue es s
Only 3 respondents (5%) reported that genetic
counselling had had an impact on family planning
(none were carriers), only 1 respondent (2%) reported
having experienced a problem with employment, and
1 respondent reported problems (2%) in obtaining 
a mortgage. Five individuals (8%), with diverse actual
risks, had experienced a problem in obtaining life
insurance due to genetic counselling.
T Ta ab bl le e   2 2. .   Levels of cancer-related distress (IES-intrusion, n=108*) as
a function of sociodemographic, clinical and psychosocial factors
C Ch ha ar ra ac ct te er ri is st ti ic cs s I IE ES S
n n m me ea an n ( (s sd d) ) p p- -v va al lu ue e
a ag ge e
20-35 years 30 5.2 (6.1)
36-50 years 48 4.4 (5.8) 0.31
51-75 years 30 6.9 (8.8)
g ge en nd de er r
male 58 4.6 (7.0) 0.24
female 50 6.1 (6.7)
l le ev ve el l   o of f   e ed du uc ca at ti io on n
low 37 6.3 (7.9)
middle 40 6.0 (7.2) 0.12
high 30 3.1 (4.5)
a ac ct tu ua al l   r ri is sk k
mutation carriers 29 5.9 (5.8)
clinical HNPCC 56 5.7 (7.6) 0.47
non-carriers 23 3.7 (6.3)
p pe er rc ce ei iv ve ed d   r ri is sk k
much higher 32 5.2 (6.2)
somewhat higher 36 5.2 (6.0) 0.96
same 31 4.8 (6.8)
lower 6 3.8 (6.4)
t tr re ea at te ed d   f fo or r   c ca an nc ce er r
yes 20 7.5 (6.9)
benign polyp  23 7.0 (8.9) 0.06
no 65 4.1 (5.8)
p pr ro of fe es ss si io on na al l   s su up pp po or rt t
ever 16 10.1 (6.8) 0.002
never 91 4.4 (6.6)
i in nv vo ol lv ve em me en nt t   i in n   d di is se ea as se e   p pr ro oc ce es ss s   o of f   r re el la at ti iv ve e
very much  63 6.3 (6.8)
quite a bit  23 5.4 (6.5) 0.24
a little/not at all 21 3.6 (7.3)
* Due to missing values for some of the variables, the total number of 
individuals in these analyses is 108.H He er re ed diit ta ar ry y  C Ca an nc ce er r  iin n  C Clliin niic ca all  P Pr ra ac ct tiic ce e 2007; 5(2) 64
D Di is sc cu us ss si io on n
This study is the first to report the results of a long-
term (i.e. more than one year) follow-up of the
psychosocial consequences of genetic counselling for
familial colorectal cancer.
D Di is st tr re es ss s
On average, four years after the completion of
genetic counselling and/or testing for colorectal cancer,
only a small minority (6%) of counselled individuals
reported having clinically significant levels of cancer-
specific distress. These rates are comparable to those
reported by Coyne et al. [46] in a study of women at
high-risk for breast cancer.
Previous contact with a professional psychosocial
worker for cancer risk was associated significantly with
current levels of cancer-specific distress. The most
plausible explanation might be that those most
distressed are most likely to seek psychosocial help
and that psychological distress is stable and persists
over time. This explanation is in line with the results of
the review of Broadstock et al. [12] and the study of
Gritz et al. [19], who found pre-genetic test mood
disturbance and lower quality of life to be the only
significant predictors of distress after genetic
counselling. However, it should be noted that the mean
score of the distressed group was still below the cut-
off score to be of clinical relevance.
One might argue that the assessment of “previous
contact with a psychosocial worker” is a proxy for
distress. However, we assessed current levels of cancer-
specific distress, versus previous psychosocial support
during the past 10 years, indicating only a possible
partial overlap. Furthermore, when excluding the
variable “previous support” from the regression
analyses, the only factor associated with cancer-specific
distress was female gender (p=0.02). Higher self-
reported levels of distress among women have been
reported in previous studies [47-50]. No other
variables contributed significantly to the prediction of
cancer-specific distress at the multivariate level,
although, at the univariate level, cancer history tended
to be associated with cancer-specific distress.
It has previously been reported that a higher
perceived breast cancer risk is associated with higher
levels of distress in high-risk women [51]. Our findings
do not confirm these results in the case of colorectal
cancer. This might suggest that those at risk for
colorectal cancer have more confidence in early
screening and treatment options than those at risk for
breast/ovarian cancer.
F Fa am mi il ly y  r re el la at ti io on ns sh hi ip ps s
Genetic counselling was found to have had 
a negative impact on family relationships in only 5%
of the cases. The impact might have been larger during
the first year, with difficulties in family communication
decreasing over time. We are currently conducting 
a longitudinal study of the psychosocial and behavioural
impact of genetic counselling for colorectal cancer. In
this study, we will be able to identify prospectively the
important predictors of distress and family functioning,
and to explore the effect of time on psychosocial well-
-being in more detail.
S So oc ci ia al l  c co on ns se eq qu ue en nc ce es s
Only a few counselees reported having experienced
problems in obtaining life insurance (8%), choice or
change of employment (2%), or obtaining a mortgage
(2%). These low levels could be due to the fact that, in
the Netherlands, there is universal health insurance
coverage, and disclosure of genetic status can only be
requested when obtaining a mortgage or life-insurance
valued at more than 160,000 Euros.
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T Ta ab bl le e   3 3. .   Family communication and social issues
Q Qu ue es st ti io on ns s a ap pp pl li ic ca ab bl le e    y ye es s % %
t to o   t to ot ta al l n n
N N
D Di id d   y yo ou u   e ex xp pe er ri ie en nc ce e   p pr ro ob bl le em ms s   i in n   t ta al lk ki in ng g   a ab bo ou ut t   g ge en ne et ti ic c   c co ou un ns se el ll li in ng g… …
– to your children 79 7 9
– to 1st degree relatives  103 7 7
(parents, brothers, sisters)
– to 2nd degree relatives 93 7 8
D Di id d   y yo ou u   e ex xp pe er ri ie en nc ce e   c ch ha an ng ge es s   i in n   r re el la at ti io on ns sh hi ip ps s   w wi it th h   r re el la at ti iv ve es s   d du ue e   
t to o   g ge en ne et ti ic c   c co ou un ns se el ll li in ng g? ?
– worse with some relatives 109 5 5
– improved with some relatives 109 12 11
– changed, but not better or worse 109 14 13
– no change in relationships 109 81 74
D Di id d   y yo ou u   e ex xp pe er ri ie en nc ce e   p pr ro ob bl le em ms s   d du ue e   t to o   g ge en ne et ti ic c   c co ou un ns se el ll li in ng g   i in n. .. .. .
– family planning 56 3 5
– (getting a) relationship 66 0 –
– choice or change of job 67 1 2
– obtaining a mortgage 67 1 2
– obtaining life insurance 66 5 8H He er re ed diit ta ar ry y  C Ca an nc ce er r  iin n  C Clliin niic ca all  P Pr ra ac ct tiic ce e 2007; 5(2) 65
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None of the carriers in our study reported negative
consequences for family planning. This is in contrast to
the results reported by Smith et al. in a study of women
at risk for breast cancer [36]. This difference might be
explained by cultural differences between the U.S. and
the Netherlands and/or differences in cancer type.
S St tr re en ng gt th hs s  a an nd d  l li im mi it ta at ti io on ns s  o of f  t th he e  s st tu ud dy y
The high response rate (81%) suggests that the results
are representative of the population requesting genetic
counselling and testing for colorectal cancer. The follow-
up period (up to 11 years) is among the longest reported
in the literature. However, due to the cross-sectional study
design, one can only speak in terms of associations
between various “predictor variables” and distress.
Without pre-counselling data, it is not possible to
establish with certainty whether the results reflect change
from pre-counselling levels of distress. Nevertheless, our
data indicate that, in the long-term, only a small minority
of individuals suffer from clinically significant levels of
cancer-specific distress. This contrasts with the literature
on the short-term prevalence of distress, where it is
reported that as many as one-quarter of individuals who
have undergone genetic counselling and/or testing for
colorectal cancer experience high levels of distress.
Similarly, while we recognize the limitations of
retrospective, self-report data on changes in family
relationships, it is encouraging that only 5% of individuals
perceived genetic counselling as having had a negative
impact on this important area of their lives. Given the
potential impact of genetic counselling for families, we
would encourage the development of more detailed,
standardized questionnaires to assess the impact of
genetic counselling on family relationships.
Finally, clinical workers should be aware that
counselees who have been in contact with 
a professional psychosocial worker in relation to their
cancer risk during the past 10 years may be at
increased risk of experiencing higher levels of distress
over the subsequent years. This knowledge can be used
as a tool to identify counselees who might benefit from
professional psychosocial support during the genetic
counselling and testing process.
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